Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -157.61M
December 31, 2024 -119.24M
December 31, 2023 -97.75M
December 31, 2022 -105.39M
Date Value
December 31, 2021 -67.74M
December 31, 2020 -41.38M
December 31, 2019 -17.81M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Silence Therapeutics Plc -62.27M
Biodexa Pharmaceuticals Plc -7.268M
NuCana Plc -9.377M
Mereo BioPharma Group Plc -31.04M
HemoGenyx Pharmaceuticals Plc -4.543M